晶澳科技(002459.SZ):美國2GW組件工廠在正常推進
格隆匯6月1日丨晶澳科技(002459.SZ)於2023年5月30日下午15:00-17:00參與河北轄區上市公司2023年投資者網上集體接待日活動,交流環節中,就“目前美國工廠是什麼進度?公司除去越南項目和美國預建項目,還有哪個國家籌建設立電池、組件基地?”,公司回覆稱,美國2GW組件工廠在正常推進,公司加大了當地人員招錄力度,積極協調當地設計單位、基礎設施有關部門加快相關工作進度。除了越南和美國項目外,目前公司尚未在其他海外國家或地區設立生產基地,未來如有相關海外項目會按照監管要求及時公吿。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.